Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
Open Access
- 1 February 2012
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 20 (2), 462-467
- https://doi.org/10.1038/mt.2011.248
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophyThe Journal of Physiology, 2011
- Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx MiceMolecular Therapy, 2011
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyThe Lancet Neurology, 2009
- By‐passing the nonsense mutation in the 4CV mouse model of muscular dystrophy by induced exon skippingThe Journal of Gene Medicine, 2008
- Sarcolemma-localized nNOS is required to maintain activity after mild exerciseNature, 2008
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophyNature Medicine, 2008
- ZZ domain of dystrophin and utrophin: topology and mapping of a β-dystroglycan interaction siteBiochemical Journal, 2007
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathologyNature Medicine, 2006
- Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotideThe Journal of Gene Medicine, 2005
- Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrixNature, 1992